BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

These five top stocks trade at reasonable levels and offer the strength that makes sense as we enter a very volatile time of ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

The Department of Health and Human Services will soon restart its program of offering free rapid tests for the virus through ...

Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based on messenger RNA - Moderna's Spikevax and Comirnaty, which is jointly developed by Pfizer ...

In Australia, our process differs slightly and tends to take a little longer. The TGA’s website indicates applications for ...

He feels the company has a sensible strategy to regain its footing somewhat after the years of the COVID-19 pandemic when Comirnaty (co-developed with German peer BioNTech) was a vaccine used to ...

According to The People’s Vaccine Alliance, Comirnaty costs an estimated $1.18 per dose to produce. For over two years now, the US government has been running its public vaccination campaign ...

KP.2-adapted COVID-19 vaccine received FDA approval. Manufacturing Optimization Program aims to deliver $1.5b in savings by ...

Moderna’s Spikevax and Pfizer’s Comirnaty are available at GIANT and MARTIN’S pharmacies — inventory may vary by location. Vaccines for those 12 years and older are readily available. Vaccines for ...